C. STEWART WALLACE, M.D., F.A.C.P.
In 1873 Lancereaux gave the first modern clinical description of bacterial endocarditis.1 From then until a few years ago, interest in the disease was largely academic. With the advent of modern chemotherapeutic agents, new interest was created in the treatment of bacterial endocarditis. The result is one of chemotherapy's greatest triumphs. A majority of the cases caused by organisms sensitive to antibiotics are being cured. A smaller number have failed to respond.
A wide variety of organisms have been described as etiologic agents in bacterial endocarditis. Various authors have estimated that the streptococcus is responsible for 90 to 95 per
WALLACE CS. BACTERIAL ENDOCARDITIS WITH EMPHASIS ON THE ESCHERICHIA-AEROBACTER GROUP AS THE CAUSATIVE AGENT: REPORT OF A FATAL CASE(BACTERIAL ENDOCARDITIS WITH EMPHASIS ON THE ESCHERICHIA-AEROBACTER GROUP AS THE CAUSATIVE AGENT: REPORT OF A FATAL CASE*). Ann Intern Med. 1951;34:1463–1472. doi: 10.7326/0003-4819-34-6-1463
Download citation file:
Published: Ann Intern Med. 1951;34(6):1463-1472.
Cardiology, Endocarditis, Infectious Disease.
Results provided by:
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use